Inactive Instrument
Company Biocorrx Inc Other OTC
Stocks
US09073C1062
Healthcare Facilities & Services
Business description: Biocorrx Inc

Sales by Activity: Biocorrx Inc
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Alcohol Addiction Treatment | 48.27K | 214K | 89.16K | 7.66K | 797K |
Geographical breakdown of sales: Biocorrx Inc
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 48.27K | 214K | 89.16K | 7.66K | 797K |
Executive Committee: Biocorrx Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Lourdes Felix
CEO | Chief Executive Officer | 58 | 2020-11-08 |
Louis Lucido
PSD | President | 77 | 2024-01-04 |
Composition of the Board of Directors: Biocorrx Inc
| Director | Title | Age | Since |
|---|---|---|---|
Lourdes Felix
BRD | Director/Board Member | 58 | 2013-03-06 |
Kent Emry
CHM | Chairman | 57 | - |
Louis Lucido
BRD | Director/Board Member | 77 | 2019-02-28 |
Luisa Ingargiola
BRD | Director/Board Member | 58 | 2018-03-31 |
Joe Galligan
BRD | Director/Board Member | 66 | 2021-02-15 |
| Director/Board Member | 65 | 2024-02-07 |
Company details: Biocorrx Inc

Other Healthcare Facilities & Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.29% | -1.28% | +44.14% | +26.87% | 121B | ||
| -0.69% | +0.70% | +5.45% | +52.73% | 89.14B | ||
| -0.73% | -1.03% | +31.84% | +74.83% | 26.05B | ||
| -1.64% | -2.56% | -9.79% | -15.72% | 21.29B | ||
| +0.10% | +4.06% | +55.38% | +261.66% | 21.5B | ||
| +6.31% | +1.41% | -6.22% | +9.83% | 14.5B | ||
| -0.05% | -2.13% | -3.64% | -13.83% | 12.53B | ||
| -1.28% | -0.83% | +33.02% | +65.36% | 11.43B | ||
| -0.86% | -6.78% | -18.05% | +91.46% | 10.29B | ||
| Average | +0.19% | -0.86% | +14.68% | +61.47% | 36.47B | |
| Weighted average by Cap. | -0.02% | -0.50% | +23.51% | +51.38% |

















